JPH03206888A - Ｈｉｖ抗原に対し特異性を持つマウス―ヒトキメラ抗体 - Google Patents

Ｈｉｖ抗原に対し特異性を持つマウス―ヒトキメラ抗体

Info

Publication number
JPH03206888A
JPH03206888A JP2308454A JP30845490A JPH03206888A JP H03206888 A JPH03206888 A JP H03206888A JP 2308454 A JP2308454 A JP 2308454A JP 30845490 A JP30845490 A JP 30845490A JP H03206888 A JPH03206888 A JP H03206888A
Authority
JP
Japan
Prior art keywords
antigen
immunoglobulin
fragment
chimeric
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2308454A
Other languages
English (en)
Japanese (ja)
Inventor
Marc D Better
マーク　ディー．ベター
Arnold H Horwitz
アーノルド　エイチ．ホーウィッツ
Pradip Ghosh-Dastidar
プラディップ　ゴーシュ―ダスティダー
Randy R Robinson
ランディ　アール．ロビンソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
GC Biopharma Corp
Xoma Royalty Corp
Original Assignee
Green Cross Corp
Green Cross Corp Korea
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp, Green Cross Corp Korea, Xoma Corp filed Critical Green Cross Corp
Publication of JPH03206888A publication Critical patent/JPH03206888A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2308454A 1989-11-13 1990-11-13 Ｈｉｖ抗原に対し特異性を持つマウス―ヒトキメラ抗体 Pending JPH03206888A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43370389A 1989-11-13 1989-11-13
US433,703 1989-11-13

Publications (1)

Publication Number Publication Date
JPH03206888A true JPH03206888A (ja) 1991-09-10

Family

ID=23721227

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2308454A Pending JPH03206888A (ja) 1989-11-13 1990-11-13 Ｈｉｖ抗原に対し特異性を持つマウス―ヒトキメラ抗体
JP3501473A Pending JPH04503609A (ja) 1989-11-13 1990-11-13 Ｈｉｖ抗原に特異性を持つキメラマウスひと抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP3501473A Pending JPH04503609A (ja) 1989-11-13 1990-11-13 Ｈｉｖ抗原に特異性を持つキメラマウスひと抗体

Country Status (6)

Country Link
EP (1) EP0453561A4 (fr)
JP (2) JPH03206888A (fr)
KR (2) KR910009285A (fr)
AU (2) AU6663990A (fr)
CA (2) CA2044609A1 (fr)
WO (1) WO1991007494A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998043995A1 (fr) * 1997-03-28 1998-10-08 Seikagaku Corporation Nouveaux complexes anti-vih et compositions medicamenteuses

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519866A1 (fr) * 1991-06-18 1992-12-23 Ciba-Geigy Ag Anticorps contre V.I.H.
US5558865A (en) * 1991-08-22 1996-09-24 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
EP0581353A1 (fr) * 1992-07-03 1994-02-02 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Anticorps monoclonaux dirigés contre HIV-1 gp120, lignées cellulaires les produisant et structures epitopiques correspondantes
WO1998001476A1 (fr) * 1996-07-10 1998-01-15 Nabi Neutralisation hautement synergique du vih par des combinaisons d'anticorps monoclonaux et polyclonaux
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
JP2005522192A (ja) 2001-07-19 2005-07-28 パーラン セラピューティクス， インコーポレイテッド マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
EP1960435A1 (fr) * 2005-12-15 2008-08-27 Micromet AG Anticorps à domaines greffés
CN105980405A (zh) * 2013-12-08 2016-09-28 派特塞尔有限公司 Hiv抗原和抗体及其组合物、方法和用途
CN116143909B (zh) * 2021-11-20 2023-10-31 东莞市朋志生物科技有限公司 一种抗hiv-1 p24的抗体及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
CA1339857C (fr) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Anticorps monoclonaux qui peuvent se fixer a la proteine gp120 et qui neutralisent le vih-1
WO1989005820A1 (fr) * 1987-12-21 1989-06-29 Arch Development Corporation Antigenes et anticorps associes au virus d'immunodeficience humaine
JP2646007B2 (ja) * 1988-01-30 1997-08-25 財団法人 化学及血清療法研究所 抗ｈｉｖ抗体可変領域をコードする遺伝子断片およびこれらを用いて発現された抗ｈｉｖキメラ抗体ならびにその製法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998043995A1 (fr) * 1997-03-28 1998-10-08 Seikagaku Corporation Nouveaux complexes anti-vih et compositions medicamenteuses

Also Published As

Publication number Publication date
KR910009285A (ko) 1991-06-28
CA2044627A1 (fr) 1991-05-14
EP0453561A1 (fr) 1991-10-30
AU6953091A (en) 1991-06-13
EP0453561A4 (en) 1993-02-10
KR920701441A (ko) 1992-08-11
AU6663990A (en) 1991-05-16
JPH04503609A (ja) 1992-07-02
WO1991007494A1 (fr) 1991-05-30
CA2044609A1 (fr) 1991-05-14

Similar Documents

Publication Publication Date Title
AU634314B2 (en) Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
US5576184A (en) Production of chimeric mouse-human antibodies with specificity to human tumor antigens
EP0120694B1 (fr) Procédés pour la production des polypeptides ou protéines à chaînes multiples
US6461824B1 (en) Production of chimeric antibodies with specificity to human tumor antigens
US6072035A (en) Reshaped monoclonal antibodies against an immunoglobulin isotype
US5958708A (en) Reshaped monoclonal antibodies against an immunoglobulin isotype
EP0314161A1 (fr) Immunoglobulines humaines produites par voie de génie génétique
US6328962B2 (en) Method for delivery of antigens to selected cells of the immune system using chimeric antibodies
CA2093099A1 (fr) Anticorps monoclonaux recombinants neutralisant le vih pour la prevention et le traitement des infections a vih
JPH025868A (ja) Ｈｉｖ結合タンパク質の発現
WO1991007493A1 (fr) Anticorps murins humains chimeriques a specificite aux antigenes du vih
AU613699B2 (en) Gene fragments coding for anti-hiv antibody variable region, anti-hiv chimeric antibody expressed using the same, and process for preparation thereof
AU6953091A (en) Chimeric mouse human antibodies with specificity to hiv antigens
US6291208B1 (en) Chimeric antibodies for delivery of antigens to selected cells of the immune system
CA2019323A1 (fr) Anticorps km10 chimeriques humain - murin specifiques contre un antigene de cellules tumorales humaines
JP3832847B2 (ja) 標的分子の細胞内結合方法
US20020025315A1 (en) Chimeric antibodies for delivery of antigens to selected cells of the immune system
WO2000042185A1 (fr) Methodes pour reguler la stabilite de proteines recombinantes, et produits utilises dans ces methodes
WO1994006469A1 (fr) Polypeptide de fusion au vih
US20050196400A1 (en) Production of chimeric mouse-human antibodies with specificity to human tumor antigens
EP0588750A2 (fr) Procédé pour la production de polypeptides recombinants contenant des épitopes dérivées d'isolées d'HIV différentes, leur utilisations comme immunigènes et pour la détection d'anticorps contre le HIV